Atraumatic spinal needles market seen reaching $0.24 billion by 2030

The atraumatic spinal needles market is projected to grow from $0.17 billion in 2025 to $0.24 billion by 2030 as demand rises for safer neuraxial procedures, spinal anesthesia and minimally invasive care. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Atraumatic spinal needles are used to reduce post-dural puncture headaches and improve safety in spinal anesthesia and lumbar puncture procedures. - Market growth reflects more surgeries, more outpatient procedures and broader use of minimally invasive medical technologies. - The trend matters for hospitals, surgical centers and device makers focused on patient recovery and infection prevention.

What happened: - The Business Research Company published its Atraumatic Spinal Needles Global Market Report 2026 covering market size, trends and forecasts through 2035. - The report says the market rose from $0.17 billion in 2025 to $0.18 billion in 2026. - The report projects the market will reach $0.24 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - More information is available in the company’s sample request and the full report.

The details: - The report puts the market’s 2025-2026 CAGR at 6.6%. - It forecasts a 6.8% CAGR from 2026 to 2030. - Growth is linked to more surgeries requiring spinal anesthesia, a higher prevalence of neurological disorders and greater awareness of post-dural puncture headaches. - Rising healthcare infrastructure and better access to minimally invasive technologies are also supporting demand. - The report says safer neuraxial procedures, outpatient surgeries, higher healthcare spending in emerging regions and more spinal anesthesia use among elderly patients will drive the next phase of growth. - Atraumatic spinal needles use a pencil-point tip that separates dural fibers instead of cutting them. - That design is intended to reduce complications and improve post-surgical recovery and comfort. - The report highlights a growing preference for pencil-point needle designs. - The report also points to rising use of disposable sterile spinal needle kits to lower infection risk during neuraxial procedures. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated technology and trend analysis.

Between the lines: - The market is being shaped less by one product shift than by a broader move toward safer, faster recovery procedures. - Disposable kits and atraumatic tips suggest hospitals are prioritizing both infection control and complication reduction. - The regional split points to a mature but still growing North American market and a larger expansion runway in Asia-Pacific. - The cited procedure growth data supports the idea that demand is being pulled by real clinical volume, not just product upgrades.

What's next: - The report expects growth to continue through 2030 as surgical volumes and spinal anesthesia use rise. - Demand should strengthen as elderly patient populations grow and outpatient surgery becomes more common. - Device makers will likely compete on needle design, sterility and ease of use as hospitals push for safer neuraxial care. - The Business Research Company lists Saumya Sahay for expert contact by phone and email at marketing@tbrc.info.

The bottom line: - Atraumatic spinal needles are moving from niche device to standard safety-focused tool in neuraxial care, with the strongest growth coming from procedures that need better outcomes and fewer complications.